Table 5

Trends in socioeconomic inequality of fatal cancer burden (years lost life/1000) by cancer type, 2011 to 2015

Cancer types/site	2011				2015				Time difference		Annual percentage change
	Q₁	Q₅	Q₁-Q₅	Q₁/Q₅	Q₁	Q₅	Q₁-Q₅	Q₁/Q₅	Q₁	Q₅	Q₁	Q₅
	(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)	(5 - 1)	(6 - 2)	(11)	(12)
Lung cancer	7.88	3.98	3.90	1.98	7.18	3.37	3.81	2.13	−0.70	−0.61	−1.84	−3.27
Bowel cancer	4.29	2.58	1.71	1.66	3.62	2.55	1.07	1.42	−0.67	−0.03	−3.34	−0.23
Breast	2.63	2.54	0.09	1.04	2.29	1.92	0.37	1.19	−0.34	−0.62	−2.73	−5.44
Pancreatic cancer	1.97	1.55	0.42	1.27	1.77	1.57	0.20	1.13	−0.20	0.02	−2.12	0.26
Prostate cancer	1.73	1.29	0.44	1.34	1.30	0.99	0.31	1.31	−0.43	−0.30	−5.55	−5.16
Brain and central nervous system	1.41	1.37	0.04	1.03	1.42	1.35	0.07	1.05	0.01	−0.02	0.14	−0.29
Cancer of unknown primary site	1.81	0.91	0.90	1.99	1.11	0.61	0.50	1.82	−0.70	−0.30	−9.32	−7.69
Melanoma	1.34	1.03	0.31	1.30	1.05	0.95	0.10	1.11	−0.29	−0.08	−4.76	−1.60
Liver cancer	1.54	0.78	0.76	1.97	1.66	0.78	0.88	2.13	0.12	0.00	1.51	0.00
Non-Hodgkin's lymphoma	1.14	0.86	0.28	1.33	0.91	0.75	0.16	1.21	−0.23	−0.11	−4.41	−2.70
Oesophageal cancer	1.15	0.62	0.53	1.85	0.89	0.63	0.26	1.41	−0.26	0.01	−5.00	0.32
Stomach cancer	1.00	0.74	0.26	1.35	0.84	0.56	0.28	1.50	−0.16	−0.18	−3.43	−5.42
Ovarian cancer	0.76	0.78	−0.02	0.97	0.67	0.61	0.06	1.10	−0.09	−0.17	−2.49	−4.80
Kidney cancer	0.80	0.59	0.21	1.36	0.60	0.45	0.15	1.33	−0.20	−0.14	−5.59	−5.27
Acute myeloid leukaemia	0.75	0.61	0.14	1.23	0.65	0.46	0.19	1.41	−0.10	−0.15	−2.82	−5.49
Bladder cancer	0.80	0.46	0.34	1.74	0.60	0.38	0.22	1.58	−0.20	−0.08	−5.59	−3.75
Myeloma	0.57	0.50	0.07	1.14	0.57	0.51	0.06	1.12	0.00	0.01	0.00	0.40
Mesothelioma	0.34	0.39	−0.05	0.87	0.32	0.37	−0.05	0.86	−0.02	−0.02	−1.21	−1.05
Lip and oral cavity	0.51	0.26	0.25	1.96	0.49	0.23	0.26	2.13	−0.02	−0.03	−0.80	−2.42
Non-melanoma skin cancer	0.37	0.19	0.18	1.95	0.41	0.19	0.22	2.16	0.04	0.00	2.07	0.00
Uterine Cancer	0.30	0.27	0.03	1.11	0.33	0.23	0.10	1.43	0.03	−0.04	1.92	−3.16
Cervical cancer	0.49	0.16	0.33	3.06	0.35	0.20	0.15	1.75	−0.14	0.04	−6.51	4.56
Blood cancer	0.28	0.26	0.02	1.08	0.29	0.20	0.09	1.45	0.01	−0.06	0.70	−5.11
Other benign, in situ and uncertain neoplasms	0.23	0.13	0.10	1.77	0.16	0.11	0.05	1.45	−0.07	−0.02	−7.00	−3.29
Benign and uncertain brain tumours	0.28	0.12	0.16	2.33	0.21	0.14	0.07	1.50	−0.07	0.02	−5.59	3.13
Gallbladder cancer	0.20	0.14	0.06	1.43	0.19	0.12	0.07	1.58	−0.01	−0.02	−1.02	−3.04
Chronic lymphocytic leukaemia	0.18	0.17	0.01	1.06	0.16	0.12	0.04	1.33	−0.02	−0.05	−2.33	−6.73
Acute lymphoblastic leukaemia	0.12	0.12	0.00	1.00	0.22	0.15	0.07	1.47	0.10	0.03	12.89	4.56
Laryngeal Cancer	0.23	0.07	0.16	3.29	0.18	0.10	0.08	1.80	−0.05	0.03	−4.78	7.39
Thyroid cancer	0.12	0.07	0.05	1.71	0.11	0.08	0.03	1.38	−0.01	0.01	−1.73	2.71
Other cancers	1.37	1.01	0.36	1.36	1.21	0.89	0.32	1.36	−0.16	−0.12	−2.45	−2.50